DEXA Bone Densitometers Market Report 2025 (Global Edition)

Global DEXA Bone Densitometers Market Report 2025 Market Size Split by Application (Osteoporosis Diagnosis, Body Composition Analysis, Fracture Risk Assessment, Others), by Technology (Central DEXA Sc...

DEXA Bone Densitometers Market Report Description

We have various report editions of DEXA Bone Densitometers Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Competitive Landscape
The DEXA bone densitometer market is moderately consolidated, with a few global players leading innovation in imaging resolution, diagnostic algorithms, and body composition integration. Companies are also emphasizing compact, portable models for point-of-care use and AI-powered tools for automated interpretation and reporting.

Recent Developments

• In June 2023, Hologic Inc. received FDA clearance for its Horizon DXA system software update that includes enhanced fracture risk algorithms and new AI-powered body composition analysis tools for clinical and wellness applications.

[Source: horizon_dxa_system_technical_and_clinical_advantages.pdf]

• In October 2023, Osteosys launched the EXA-3000, a compact, transportable DEXA system targeting small clinics and wellness centers in Southeast Asia, combining spine and hip scanning with real-time image processing.

[Source: EXA-3000 – OSTEOSYS, BETTER PRODUCTS FOR BETTER LIFE]

Top Companies Market Share in DEXA Bone Densitometers Industry: (In no particular order of Rank)

• Hologic Inc.
• GE Healthcare
• DMS Imaging
• Swissray
• Medilink
• Osteosys
• Scanflex Healthcare
• Norland (CooperSurgical)
• Echolight
• BeamMed Ltd.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Which Region Dominates the Market?

North America holds the largest share of the DEXA bone densitometer market, driven by high osteoporosis awareness, routine preventive care policies, and advanced healthcare infrastructure. The U.S. Preventive Services Task Force (USPSTF) recommends routine BMD testing for all women aged 65 and older, a guideline supported by Medicare and commercial insurers.
[Source: Recommendation: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce]
Moreover, leading manufacturers such as Hologic Inc. and GE Healthcare have established robust distribution and service networks across the U.S. and Canada. Integration with digital health records and AI-supported reporting is also enhancing diagnostic throughput in North American imaging centers.
[Source: Recommendation: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce 
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening]

Which is the Fastest Growing Region in the Market?

Asia Pacific is the fastest-growing region, fuelled by a rapidly aging population, increased urban healthcare access, and growing adoption of preventive diagnostics. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the region will host over 1.3 billion people aged 60+ by 2050, amplifying the risk pool for osteoporosis.
[Source: https://www.unescap.org/sites/default/files/SDD%20Ageing%20Fact%20Sheet%20Overview.pdf]
Governments in countries such as China, Japan, and South Korea are expanding public health programs to include bone health screening. Additionally, domestic manufacturers are introducing cost-effective, compact DEXA solutions tailored for smaller clinics and rural health networks.
[Source: https://www.unescap.org/kp/2022/escap-population-data-sheet-2022 , Osteoporosis prevention and osteoporosis exercise in community-based public health programs - PMC]
 

The current report Scope analyzes DEXA Bone Densitometers Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

DEXA Bone Densitometers Market Analysis

Segment Analysis of DEXA Bone Densitometers Market

This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.

Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments

of DEXA Bone Densitometers analyzed in this report are as follows:

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of DEXA Bone Densitometers Industry. Request a Free Sample PDF!

Application Segment Analysis of DEXA Bone Densitometers Market

This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.

Some of the key Application of DEXA Bone Densitometers are:

• Osteoporosis Diagnosis
• Body Composition Analysis
• Fracture Risk Assessment
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

DEXA Bone Densitometers Technology Segment Analysis

The market is segmented into Central DEXA Scanners and Peripheral DEXA Scanners.
Central DEXA scanner dominate the market due to their ability to measure bone density in the hip and spine—the most clinically relevant sites for fracture risk assessment. These devices are preferred in hospital and diagnostic imaging settings due to their high precision and diagnostic confidence.

• Central DEXA Scanners
• Peripheral DEXA Scanners

DEXA Bone Densitometers End - Use Industry Segment Analysis

• Hospitals
• Diagnostic Centers
• Specialty Clinics
• Academic & Research Institutes

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion